Association of circulating endothelial progenitor cells (CD14 +-EPC) with renal function in patients with coronary artery disease

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The relationships between the endothelial progenitor cells (EPCs)-CD34+ and CD14+ and coronary artery disease (CAD) were reported and the association of CD34+ cells with renal function was studied previously. Another kind EPCCD14+ cell and its association with renal function in patients with CAD have not been reported yet. Our aim was to assess CD14+ cell counts versus renal function in CAD. Methods and Results: We studied 242 patients with severe angiographic CAD and 30 healthy control participants. The CD14+ cells were enumerated by flow cytometry. With lowering glomerular filtration rate (GFR), CD14 + cell numbers (percentage of lymphocytes, median and interquartile range) decreased: 0.04 (0.03-0.06), 0.03 (0.02-0.05), 0.02 (0.01-0.03) for estimated glomerular filtration rate (eGFR) ≥90, 60 to 89, and 30 to 89 mL/min per 1.73 m2, respectively (P < .001 for trend). The CD14+ cell counts correlated with eGFR (r = .27, P = .03). By multivariate liner regression analysis, the difference remains significant (P = .02). Conclusions: The CD14+ cell depletion is associated with renal dysfunction in CAD. © 2013 The Author(s).

Cite

CITATION STYLE

APA

Li, G. Q., Yang, Y., Ke, D. Z., Li, X. S., Wu, Q., Cao, G. Y., & Chen, Q. W. (2013). Association of circulating endothelial progenitor cells (CD14 +-EPC) with renal function in patients with coronary artery disease. Clinical and Applied Thrombosis/Hemostasis, 19(6), 632–636. https://doi.org/10.1177/1076029612447677

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free